Spondyloarthropathies

Top Story

Adalimumab, IBI303 biosimilar demonstrate comparable safety, efficacy in AS

September 19, 2019
In the Journals

Newly diagnosed cases of AS at increased risk for IMIDs, lower risk for RA

September 16, 2019
Newly diagnosed patients with ankylosing spondylitis in Taiwan demonstrate increased risks for multiple immune-mediated inflammatory diseases, including acute anterior…
In the Journals

Quarter of axial SpA patients attain inactive disease after 6 months on first TNF inhibitor

September 11, 2019
Among patients with axial spondyloarthritis receiving their first TNF inhibitor, 27% achieve inactive disease, defined by the Ankylosing Spondylitis Disease Activity…
Q&A With Healio Rheumatology

For IBD-associated arthritis, disease control is becoming a team sport

September 6, 2019
Rheumatologists are generally familiar with complicated case patients who require management across specialties. The same goes for gastroenterologists. But a little more…
More Headlines »
CME

Early Diagnosis & Optimal Care of Ankylosing Spondylitis

This activity is supported by an independent educational grant from AbbVie.

Ankylosing spondylitis (AS), the most common spondyloarthropathy, is a chronic, progressive, debilitating inflammatory…
More »
Video
Meeting News

VIDEO: Rheumatologists miss patients with axial spondyloarthritis

March 26, 2017
More »
CME

Updates in PsA and SpA: Optimizing Care Among the Latest Advances

This activity is supported by an educational grant from Lilly.

Chronic inflammatory diseases, such as psoriatic arthritis (PsA) and ankylosing spondylitis (AS), represent a group of…
More »